First Ophthalmic Formulation Of Bevacizumab Among New Filings At EMA

 
• By Neena Brizmohun

Using the cancer drug off-label to treat wet AMD has been controversial.

Europe
New products are under review for potential approval in Europe • Source: Shutterstock

More from Europe

More from Geography